The specific activation of the immune system to control cancer growth in vivo has been a long-standing goal in cancer immunology and medical oncology. The identification of tumor-associated antigens has provided the basis for new concepts in antigen-specific immunotherapy. The first clinical trials
Specific cancer immunotherapy
β Scribed by Morton D. Prager
- Publisher
- Springer-Verlag
- Year
- 1978
- Tongue
- English
- Weight
- 588 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract We investigated the efficacy of a preparation containing High Five (H5) insect cells infected with recombinant baculovirus encoding the murine interferonβΞ² gene (H5BVIFNβΞ²) against established primary tumors and occult lung metastases. Injection of live or lyophilized H5BVIFNβΞ² into est
Treatments available for metastatic prostate cancer have failed to demonstrate significant curative potential. Current efforts are now directed towards developments of novel strategies for the treatment of metastatic prostate cancer. Cancer immunotherapeutic strategies utilize patient immune system